Incyte Corp. (INCY)
NASDAQ
Real-time Data
01:30 PM
Day's Range
112.4652 wk Range
82.82Overview - INCY - Incyte Corp.
Key Statistics
Valuation
Enterprise Value
20.76B
P/E (Trailing)
‪15.87‬
P/E (Forward)
‪14.02‬
PEG Ratio
‪0.39‬
Price / Sales (TTM)
‪4.34‬
Price / Book
‪3.94‬
EV / EBITDA
‪10.69‬
Profitability
Gross Margin
‪93.72%‬
Profit Margin
‪27.70%‬
Operating Margin
‪41.89%‬
Return on Assets
‪16.83%‬
Return on Equity
‪30.66%‬
Ownership
Shares Outstanding
200.97M
Float
170.74M
Short % of Shares Outstanding
‪7.88%‬
Held by Insiders
‪1.84%‬
Held by Institutions
‪103.48%‬
Price stats
Beta
‪0.77‬
50-Day Avg
‪122.91‬
200-Day Avg
‪106.00‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
28 analysts
Average price target
‪$ 125.17‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - INCY - Incyte Corp.
Peers - INCY - Incyte Corp.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- INCYNASDAQIncyte Corporation25.11BMarket Cap+33.25%52-week change15.88P/E (Trailing)‪27.70%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - INCY - Incyte Corp.
About
Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics for serious medical conditions. The company concentrates on hematology and oncology, as well as inflammation, autoimmunity, and dermatology, addressing diseases with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
